172 related articles for article (PubMed ID: 36198437)
1. CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.
Dong M; Qian M; Ruan Z
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36198437
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
[TBL] [Abstract][Full Text] [Related]
3. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
Zhang L; Wang X; Li Y; Han J; Gao X; Li S; Wang F
Clin Transl Med; 2021 Sep; 11(9):e464. PubMed ID: 34586738
[TBL] [Abstract][Full Text] [Related]
4. Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate.
Bunce MW; Boronenkov IV; Anderson RA
J Biol Chem; 2008 Mar; 283(13):8678-86. PubMed ID: 18218622
[TBL] [Abstract][Full Text] [Related]
5. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma.
Yu Z; Wu X; Zhu J; Yan H; Li Y; Zhang H; Zhong Y; Lin M; Ye G; Li X; Jin J; Li K; Wang J; Zhuang H; Lin T; He J; Lu C; Xu Z; Zhang X; Li H; Jin X
Cell Mol Life Sci; 2024 Feb; 81(1):82. PubMed ID: 38340178
[TBL] [Abstract][Full Text] [Related]
6. SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis.
Gao K; Shi Q; Gu Y; Yang W; He Y; Lv Z; Ding Y; Cao W; Wang C; Wan X
Cell Death Differ; 2023 Feb; 30(2):475-487. PubMed ID: 36481790
[TBL] [Abstract][Full Text] [Related]
7. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
Kwon JE; La M; Oh KH; Oh YM; Kim GR; Seol JH; Baek SH; Chiba T; Tanaka K; Bang OS; Joe CO; Chung CH
J Biol Chem; 2006 May; 281(18):12664-72. PubMed ID: 16524876
[TBL] [Abstract][Full Text] [Related]
8. Correction: CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38101867
[No Abstract] [Full Text] [Related]
9. The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells.
Sakaue T; Sakakibara I; Uesugi T; Fujisaki A; Nakashiro KI; Hamakawa H; Kubota E; Joh T; Imai Y; Izutani H; Higashiyama S
Sci Rep; 2017 Feb; 7():42845. PubMed ID: 28216678
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils.
Shang A; Wang W; Gu C; Chen C; Zeng B; Yang Y; Ji P; Sun J; Wu J; Lu W; Sun Z; Li D
J Exp Clin Cancer Res; 2019 Sep; 38(1):411. PubMed ID: 31533774
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
[TBL] [Abstract][Full Text] [Related]
12. Sorting nexin 6 interacts with Cullin3 and regulates programmed death ligand 1 expression.
Ghosh C; Xing Y; Li S; Hoyle RG; Sun M; Li J; Sun Y
FEBS Lett; 2021 Oct; 595(20):2558-2569. PubMed ID: 34510437
[TBL] [Abstract][Full Text] [Related]
13. SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization.
Wu J; Wu Y; Guo Q; Chen S; Wang S; Wu X; Zhu J; Ju X
J Transl Med; 2022 Aug; 20(1):384. PubMed ID: 36042498
[TBL] [Abstract][Full Text] [Related]
14. The Roles of SPOP in DNA Damage Response and DNA Replication.
Maekawa M; Higashiyama S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023230
[TBL] [Abstract][Full Text] [Related]
15. Expression of STAT1 is positively correlated with PD-L1 in human ovarian cancer.
Liu F; Liu J; Zhang J; Shi J; Gui L; Xu G
Cancer Biol Ther; 2020 Oct; 21(10):963-971. PubMed ID: 33043814
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers.
Alwosaibai K; Aalmri S; Mashhour M; Ghandorah S; Alshangiti A; Azam F; Selwi W; Gharaibeh L; Alatawi Y; Alruwaii Z; Alsaab HO
BMC Cancer; 2023 Jan; 23(1):13. PubMed ID: 36604635
[TBL] [Abstract][Full Text] [Related]
18. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.
Zhuang M; Calabrese MF; Liu J; Waddell MB; Nourse A; Hammel M; Miller DJ; Walden H; Duda DM; Seyedin SN; Hoggard T; Harper JW; White KP; Schulman BA
Mol Cell; 2009 Oct; 36(1):39-50. PubMed ID: 19818708
[TBL] [Abstract][Full Text] [Related]
19. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression.
Yahata T; Mizoguchi M; Kimura A; Orimo T; Toujima S; Kuninaka Y; Nosaka M; Ishida Y; Sasaki I; Fukuda-Ohta Y; Hemmi H; Iwahashi N; Noguchi T; Kaisho T; Kondo T; Ino K
Cancer Sci; 2019 Apr; 110(4):1279-1292. PubMed ID: 30702189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
